Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences, Cancer Institutes, Fudan University, Shanghai 200032, China.
Key Laboratory of Breast Cancer in Shanghai, The Shanghai Key Laboratory of Medical Epigenetics, Fudan University, Shanghai 200032, China.
Cells. 2021 Apr 30;10(5):1070. doi: 10.3390/cells10051070.
Cancer stem cells (CSCs) refer to a subpopulation of cancer cells responsible for tumorigenesis, metastasis, and drug resistance. Increasing evidence suggests that CSC-associated tumor neovascularization partially contributes to the failure of cancer treatment. In this review, we discuss the roles of CSCs on tumor-associated angiogenesis via trans-differentiation or forming the capillary-like vasculogenic mimicry, as well as the roles of CSCs on facilitating endothelial cell-involved angiogenesis to support tumor progression and metastasis. Furthermore, we discuss the underlying regulation mechanisms, including the intrinsic signals of CSCs and the extrinsic signals such as cytokines from the tumor microenvironment. Further research is required to identify and verify some novel targets to develop efficient therapeutic approaches for more efficient cancer treatment through interfering CSC-mediated neovascularization.
癌症干细胞(CSCs)是指一群能够引发肿瘤生成、转移和耐药的肿瘤细胞。越来越多的证据表明,与 CSC 相关的肿瘤新生血管形成在一定程度上导致了癌症治疗的失败。在这篇综述中,我们讨论了 CSCs 通过转分化或形成毛细血管样血管生成拟态在肿瘤相关血管生成中的作用,以及 CSCs 促进内皮细胞参与血管生成以支持肿瘤进展和转移的作用。此外,我们还讨论了潜在的调节机制,包括 CSCs 的内在信号和肿瘤微环境中细胞因子等外在信号。需要进一步的研究来确定和验证一些新的靶点,以通过干扰 CSC 介导的新生血管形成来开发更有效的癌症治疗方法。